| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10096-013-2046-Y |
| P698 | PubMed publication ID | 24500598 |
| P2093 | author name string | B Y Lee | |
| R K Shields | |||
| M H Nguyen | |||
| C J Clancy | |||
| S M Bartsch | |||
| D R Stuckey | |||
| P2860 | cites work | Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers | Q24241136 |
| What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus control measures are negative (and other advice to young epidemiologists): a revi | Q30441728 | ||
| Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later | Q30468607 | ||
| Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study | Q30570122 | ||
| Cost-effectiveness of gargling for the prevention of upper respiratory tract infections | Q33393454 | ||
| One thousand health-related quality-of-life estimates | Q33937445 | ||
| Is surgery for displaced, midshaft clavicle fractures in adults cost-effective? Results based on a multicenter randomized, controlled trial | Q33943651 | ||
| Economics and preventing hospital-acquired infection | Q34907447 | ||
| Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? | Q36087307 | ||
| The economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus | Q36351234 | ||
| Cost-effectiveness of sirolimus therapy with early cyclosporin withdrawal vs. long-term cyclosporin therapy in Australia | Q36536752 | ||
| The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA. | Q36557836 | ||
| Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. | Q36907900 | ||
| Screening cardiac surgery patients for MRSA: an economic computer model. | Q37147604 | ||
| Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury | Q37277724 | ||
| A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients | Q37855078 | ||
| Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes | Q39551380 | ||
| Endoscopic versus open carpal tunnel release: a cost-effectiveness analysis | Q40843571 | ||
| Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis | Q40872069 | ||
| Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States | Q42825206 | ||
| Minimizing surgical-site infections | Q43201080 | ||
| Preventing surgical-site infections in nasal carriers of Staphylococcus aureus | Q43201082 | ||
| The cost-effectiveness of induction immunosuppression in kidney transplantation. | Q43481138 | ||
| A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? | Q44930328 | ||
| Cost-effectiveness analysis of the treatment of ventilator-associated pneumonia with linezolid or vancomycin in Spain | Q46514194 | ||
| Digital decision making: computer models and antibiotic prescribing in the twenty-first century | Q48533153 | ||
| Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. | Q50656512 | ||
| Technology assessment of the Dutch Lung Transplantation Program. | Q52242356 | ||
| A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economic Study Group. | Q53960705 | ||
| Screening Inpatients for MRSA — Case Closed | Q57203895 | ||
| The utility of different health states as perceived by the general public | Q67429353 | ||
| Cost-utility analysis of contaminated appendectomy wounds | Q71958754 | ||
| Toward consistency in cost-utility analyses: using national measures to create condition-specific values | Q74660492 | ||
| Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease | Q80198429 | ||
| Pertussis in adolescents and adults: should we vaccinate? | Q81805817 | ||
| Age-specific complications among lung transplant recipients 60 years and older | Q82819067 | ||
| P433 | issue | 6 | |
| P921 | main subject | lung transplant | Q1637912 |
| Staphylococcus aureus | Q188121 | ||
| computer simulation | Q925667 | ||
| P304 | page(s) | 1053-1061 | |
| P577 | publication date | 2014-02-07 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | A computer simulation model of the cost-effectiveness of routine Staphylococcus aureus screening and decolonization among lung and heart-lung transplant recipients | |
| P478 | volume | 33 |
| Q36675240 | Decolonization in Prevention of Health Care-Associated Infections |
| Q38275128 | Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus. |
| Q40049276 | Infection Prevention in Transplantation |
| Q94476129 | Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients |
Search more.